Pharmacodynamic activity of ertapenem versus multidrug-resistant genotypically characterized extended-spectrum -lactamase-producing Escherichia coli using an in vitro model | Zendy

George G. Zhanel | Zendy; Patricia J. Baudry | Zendy; Vandana Vashisht | Zendy; Nancy M. Laing | Zendy; Ayman Noreddin | Zendy; D. J. Hoban | Zendy

Open Access

Pharmacodynamic activity of ertapenem versus multidrug-resistant genotypically characterized extended-spectrum -lactamase-producing Escherichia coli using an in vitro model

Author(s) -

George G. Zhanel,

Patricia J. Baudry,

Vandana Vashisht,

Nancy M. Laing,

Ayman Noreddin,

D. J. Hoban

Publication year - 2008

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkm533

Subject(s) - ertapenem , microbiology and biotechnology , escherichia coli , pharmacodynamics , multiple drug resistance , antimicrobial , cephalosporin , biology , antibiotics , medicine , pharmacokinetics , antibiotic resistance , pharmacology , meropenem , biochemistry , gene

This study assessed the pharmacodynamic activity of ertapenem against multidrug-resistant (MDR) genotypically characterized extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli using an in vitro model.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research